FAST NEWS: Everest Medicines Hits New Low after New CEO Announcement
The latest: Innovative drug maker Everest Medicines Ltd. (1952.HK) on Monday announced the appointment of Luo Yongqing, formerly president and general manager of Greater China for Brii Biosciences Ltd. (2137.HK),…
Everest Medicines Descends to New Depths on String of Bad News
The drug maker’s shares hit all-time lows after it announced the loss of a key product, poor financial results and the resignation of its CEO Key Takeaways: The CEO of…
RELATED ARTICLES
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK -
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
BRIEF: Everest unveils positive results for kidney drug EVER001 in Phase 1b/2a trial
1952.HK
-
NEWS WRAP: DouYu names new CEO, declares massive dividend to entice investors
DOYU.US
- As Covid drug cash dwindles, Vigonvita targets new remedies
